CompaniesDermik Laboratories

Dermik Laboratories

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

2

As Collaborator

2

Total Enrollment

1,147

By Phase

NA: 2

By Status

RECRUITING: 1COMPLETED: 1TERMINATED: 1UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT03584893
NCT04113083
Hover over trial bars to see details

Recent Trials

NCT06453512Lead Sponsor
A Study to Evaluate the Emollient Performance of Doublebase Once in the Treatment of Atopic Eczema
NARecruiting
65 participants
Started: Oct 30, 2024 · Completed: Oct 1, 2025
NCT05454722Lead Sponsor
A Study to Evaluate Adex Gel in the Treatment of Atopic Eczema.
NACompleted
60 participants
Started: Nov 16, 2022 · Completed: Mar 28, 2024
NCT04113083Collaborator
An Observational Study for Evaluation of for the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disease
N/ATerminated
22 participants
Started: Oct 19, 2019 · Completed: Jun 10, 2022
NCT03584893Collaborator
The Prevalence of CTX Disorder in Juvenile Cataract Cases in Turkey
N/AUnknown
1,000 participants
Started: Jun 1, 2018 · Completed: Mar 1, 2023
Related Companies
Valeant Jul 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired